Definitive Contract 75A50120C00125
Award Date 6/11/20
Potential Completion Date 6/10/23
Potential Value $750K
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Inflammatix, Inc., a self-certified small disadvantaged business. The contract is for the development of the HOSTDX-Sepsis diagnostic test, a rapid point-of-care test that analyzes the host immune response to detect and classify sepsis. The contract has a firm fixed price of $510,000.00 and a completion date of November 30, 2021....
- This is a $27,992,718.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Inflammatix, Inc., a self-certified small disadvantaged business, for the development of a full stack of host-response solutions to address infectious disease testing for acute infections and sepsis. The contract is for the period of September 25, 2019 through May 7, 2027 and is a cost-sharing arrangement. No set-aside was used for this award....
- This contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business, for the development of a host-response prognostic tool called HOSTDXTM-COVID SEVERITY. The $453,851.00 contract is for research, development, and testing services related to diagnostic solutions for COVID-19 and other viral pandemics. Inflammatix has received over $29 million in federal contracts and grants from the Department of Health and Human Services to...
- This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
- This federal contract award, valued at $14,400, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). The contract was awarded to Immunoscape Pte. LTD., a for-profit limited liability company registered in Singapore. The contract was a purchase order for "COVID CELL PROFILING SERVICE" and was related to the Coronavirus COVID-19 national emergency...
- This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
- This is a $2,596,000.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The purpose of this firm-fixed-price contract is to procure over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of February 15, 2023 and was awarded on December 7, 2022. No set-aside designation was used for...
- This is a $24,631,080.00 definitive cost-reimbursement contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Sapphiros LLC, a for-profit foreign-owned organization. The contract is for the advanced research and development of a low-cost, connected, digital lateral flow platform to detect influenza A, influenza B, and SARS-CoV-2 for use in over-the-counter (OTC) settings. This contract was...
- This contract was awarded by the Defense Health Agency, a defense agency, to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company. The $3,574,052.08 firm-fixed-price purchase order is for a molecular assay-analyzer system capable of testing for respiratory, blood culture, gastrointestinal, and meningitis/encephalitis targets, including COVID-19. The contract has an ultimate completion date of April 15, 2025. The original solicitation was a notice of intent to sole source the...